Loncar China BioPharma ETF (CHNA) は上場企業です 金融 セクターの Asset Management 業界で事業展開.
CHNA を有する IPO日 2018-08-15, に上場 NASDAQ Global Market.
The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.
